Ariad's "Poison Pill" Plan Comes After Former Icahn Exec Buys Stake
Investors seem boyed by Ariad Pharmaceuticals’ decision Friday to adopt a plan designed to prevent takeovers, raising the company’s stock price 22 percent since the Friday morning announcement...
Related Articles
- Hewlett-Packard Shakes Up Management, Raises Outlook also mentions Management
- Tensions with the Board Not the Norm, Say 98 Percent of CEOs also categorized in BoardNews
- Ariad CEO to Retire Due to Pressure From Shareholders also written by Don Seiffert
- New Baxter CEO Steps Down From EMC Board also published in Business News
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also categorized in BoardNews
- Executive Compensation: What Will 2012 Bring? — The Harvard Law School Forum on Corporate Governance and Financial Regulation also categorized in BoardNews
- 2011 Annual Corporate Governance Review — The Harvard Law School Forum on Corporate Governance and Financial Regulation also categorized in BoardNews
- Analyst: Icahn May Urge Separation of CEO. Chairman Roles at Nuance also written by Don Seiffert
- Boardmember.com's 10 Most Viewed Articles of 2011 also categorized in BoardNews
- Care.com Shutting Down e-Commerce Firm it Previously Acquired, Loses Board Member also published in Business News
Login to comment.